NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/02/2022
Back to search
Official data from USPTO
THERASCREEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THERASCREEN
ST13
US500000079087792Class
1, 5
Filing
79087792
Registration
4036966
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
05/02/2022
Trademark type
Word
Nice classes
1, 5
Filing date
02/11/2010
Registration date
10/11/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/02/2022
Last transaction
05/02/2022
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
Manchester, GB
Examiner
BEN, LINDSEY
Law office
L80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
QIAGEN Manchester Limited
QIAGEN Manchester Limited
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemical preparations for use in analyzing DNA or RNA for scientific purposes; kits comprising chemical preparations for use in analyzing DNA or RNA for scientific purposes
Class 5
chemical preparations for laboratory and diagnostic use in the medicalveterinary or pharmaceutical fieldchemical preparations for use in relation to the detectiontreatment and monitoring of cancerinherited diseasegenetic predispositionsdrug responsesmonitoring of tumors; diagnostic preparations for medicalveterinary or pharmaceutical use for use in relation to the detectiontreatment and monitoring of cancerinherited diseasegenetic predispositionsdrug responsesmonitoring of tumorsanalysis of DNA or RNA; kits comprising chemical preparations and diagnostic preparations for medicalveterinary or pharmaceutical use for use in relation to the detectiontreatment or monitoring of cancerinherited diseasegenetic predispositionsdrug responsesmonitoring of tumors and analysis of DNA or RNA
Publications
History of USPTO decisions and trademark events.
50 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
05/02/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/27/2022
ES71
TEAS SECTION 71 RECEIVED
09/20/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/21/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/21/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/21/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/21/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/21/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/21/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/21/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
10/11/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/27/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/27/2019
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
10/25/2017
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
10/25/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/24/2017
ES75
TEAS SECTION 71 & 15 RECEIVED
09/25/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/22/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/12/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/04/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/17/2012
FIMP
FINAL DISPOSITION PROCESSED
04/17/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/11/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
10/11/2011
PUBO
PUBLISHED FOR OPPOSITION
07/26/2011
NPUB
NOTICE OF PUBLICATION
07/06/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/23/2011
ALIE
ASSIGNED TO LIE
06/20/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/20/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/18/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/17/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/17/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/28/2011
GNRT
NON-FINAL ACTION E-MAILED
04/28/2011
CNRT
NON-FINAL ACTION WRITTEN
04/28/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/05/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/05/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/05/2011
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/07/2011
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/31/2010
RFNT
REFUSAL PROCESSED BY IB
12/11/2010
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/05/2010
RFRR
REFUSAL PROCESSED BY MPU
11/05/2010
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/04/2010
CNRT
NON-FINAL ACTION WRITTEN
11/03/2010
MAFR
APPLICATION FILING RECEIPT MAILED
11/02/2010
DOCK
ASSIGNED TO EXAMINER
10/29/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/29/2010
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/28/2010
Continuous trademark protection
Get notified about every new filing that threatens THERASCREEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.